查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
醫用導管市場（按應用、材料、結構和地區）- 預測至2030年
市場調查報告書
商品編碼
1700507

醫用導管市場（按應用、材料、結構和地區）- 預測至2030年

Medical Tubing Market by Material, Application, Structure - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 253 Pages | 訂單完成後即時交付

價格

預計醫用導管市場將從 2025 年的 125.3 億美元成長到 2030 年的 184.1 億美元，預測期內的複合年成長率為 8.0%。

醫用導管市場的擴大是由於心血管疾病、癌症、呼吸系統疾病等慢性疾病的增加。許多此類疾病需要導管、輸液機和人工呼吸器等醫療設備才能有效治療和控制。例如，氣喘和結核病等呼吸系統疾病的日益流行正在推動對呼吸機管道系統的需求。另一個主要原因是老齡人口不斷成長，他們更容易患慢性疾病和接受手術。隨著老齡人口的成長，微創手術的需求不斷增加，醫用導管已成為藥物輸送和輸液系統的關鍵組成部分。此外，包括產品發布和合併在內的策略性企業措施正在擴大市場覆蓋範圍和知名度。最後，嚴格的監管要求和政府對醫療保健基礎設施的支出透過為各種應用提供高品質的管道產品來推動市場成長。所有這些因素預計將在未來幾年推動醫用導管市場的長期成長。

研究範圍
調查年份 2022-2030
基準年 2024
預測期 2025-2030
對價單位 金額（百萬美元）、數量（千噸）
部分 按用途、材料、結構、地域
目標區域 北美、歐洲、亞太地區、南美、中東和非洲

橡膠是成長速度第二快的醫用導管材料，因為它具有柔韌性、耐用性和生物相容性，適用於許多醫療應用。天然橡膠和合成橡膠，例如矽膠、乳膠和熱可塑性橡膠(TPE)，具有出色的耐極端溫度、耐化學品和多次滅菌循環的性能。這使得橡膠管成為導管、呼吸治療裝置、蠕動幫浦、手術引流系統等的理想選擇。矽膠橡膠因其優異的生物相容性而廣泛應用，被認為是可植入、長期醫療應用的首選材料。此外，橡膠產品具有很強的彈性，使醫用導管能夠承受彎曲和拉伸而不會失去完整性，從而提高患者的舒適度和設備性能。心血管疾病和呼吸系統疾病等慢性疾病的日益流行推動了對採用橡膠管的醫療設備的需求。此外，橡膠複合材料的進步（例如抗菌塗層和提高的拉伸強度）也為重症加護應用做出了貢獻。隨著醫療保健創新的不斷進行，橡膠管仍然是首選，並且是醫療管道市場中第二快成長的材料。

編織管是成長速度第二快的醫用管道結構，因為它具有強度高、柔韌性好、多功能性，適用於各種先進的醫療應用。內部插入不銹鋼或尼龍等增強編織層的聚合物管比非增強管更耐高壓和扭結。這使得它們非常適合導管、內視鏡和心血管設備等高性能應用，這些應用的耐用性和精確的流體傳輸至關重要。微創手術的需求日益成長，需要管道能夠穿過複雜的解剖路徑而不會影響性能，這也大大擴展了編織管的應用。編織管還可以幫助滿足醫療領域的嚴格安全要求，因為它可以承受滅菌過程並在應力條件下保持其結構完整性。慢性病的增加、人口老化以及對先進診斷和治療設備的需求也在推動市場成長。新的編織技術和材料科學使它們更加靈活和可客製化，以滿足特定的醫療需求。雖然單腔管在簡單性和普遍性方面可能是罪魁禍首，但編織管在高性能應用中的卓越機械性能和生物相容性使其能夠快速進入滿足現代醫療保健不斷變化的需求的市場。

導管和套管市場是醫療管道市場中成長速度第二快的應用，這歸因於其需求背後的一些關鍵促進因素。隨著世界各地的醫療保健系統更加重視微創干預，導管套管正成為首選工具，為傳統手術提供更安全、更少創傷的替代方案。這些軟管在精確度和患者舒適度至關重要的應用中發揮著至關重要的作用，例如心血管介入、尿液引流和靜脈治療。此外，心血管疾病、糖尿病和腎臟疾病等慢性疾病的盛行率不斷上升，尤其是在高齡化社會中，這也刺激了導管治療的擴展。治療心臟病和尿失禁時對導管的需求自然增加了對專用管的需求。此外，矽膠和聚氨酯等生物相容性材料的改進提高了導管和套管的功能性、使用壽命和安全性，進一步促進了技術進步。此外，向門診護理和家庭醫療保健的轉變正在增加輸液幫浦等可攜式設備的應用。該領域受到醫療保健投資增加的推動，特別是在新興領域，從而加強了基礎設施並改善了醫療服務，從而推動了對一次性和無菌管的需求。

由於醫療保健投資的增加、醫療保健基礎設施的加強以及對高科技醫療設備的需求不斷成長，中東和非洲是醫用導管成長速度第二快的市場。地區政府，特別是沙烏地阿拉伯、阿拉伯聯合大公國和南非的政府，正在大力投資醫療保健現代化，從而產生了對醫院、診所、診斷中心等使用的優質醫用管道的需求。醫療設施的成長加上醫療自由區和製造中心的建立，導致當地醫療管道和相關設備的生產和分銷增加。糖尿病、心血管疾病和呼吸系統疾病等慢性疾病的增多推動了藥物輸送系統、導管和呼吸設備中醫用管道的使用。此外，該地區老年人口不斷成長，對先進醫療的需求不斷增加，推動了基於醫療管道的應用。向家庭醫療保健和穿戴式醫療設備（如胰島素幫浦和氧氣療法設備）的轉變也是市場成長的一個主要因素。全球醫療設備製造商正在透過合作、合資和建立當地製造基地擴大其在中東和非洲地區的業務。這種成長將帶來更多優質的醫用導管產品，減少對進口的依賴，從而帶來更實惠的醫療保健。隨著醫療保健專業人員繼續優先考慮感染控制和環境管理，生物分解性和抗菌醫用導管等醫用導管技術在 MEA 中變得越來越普遍。

本報告研究了全球醫用導管市場，並總結了應用、材料、結構和地區的趨勢，以及參與市場的公司概況。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章重要考察

第5章市場概述

  • 介紹
  • 市場動態
  • 波特五力分析
  • 主要相關人員和採購標準
  • 總體經濟指標
    • 全球GDP趨勢

第6章 產業趨勢

  • 介紹
  • 價值鏈分析
  • 監管狀況
    • 規則
    • 標準
    • 監管機構、政府機構和其他組織
  • 貿易分析
  • 生態系分析
  • 影響客戶業務的趨勢/中斷
  • 案例研究分析
  • 技術分析
  • 2025年主要會議和活動
  • 專利分析
  • 人工智慧/生成式人工智慧對醫用導管市場的影響
  • 定價分析
  • 投資金籌措場景

第7章 醫用導管市場（依應用）

  • 介紹
  • 散裝一次性管
  • 導管和套管
  • 藥物輸送系統
  • 其他

第8章 醫用導管市場（依材料）

  • 介紹
  • 塑膠
  • 橡皮
  • 特種聚合物
  • 其他

第9章 醫用導管市場（依結構）

  • 介紹
  • 單腔
  • 共擠
  • 多重腔
  • 錐形或凸起管
  • 編織管

第 10 章 醫用導管市場（按地區）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 荷蘭
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 其他
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 埃及
    • 其他
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他

第11章競爭格局

  • 概述
  • 主要參與企業的策略/優勢，2020-2025
  • 2024年收益分析
  • 2024年市場佔有率分析
  • 估值和財務指標
  • 品牌比較
  • 公司估值矩陣：2024 年主要參與企業
  • 公司估值矩陣：Start-Ups/中小企業，2023 年
  • 競爭場景

第12章 公司簡介

  • 主要參與企業
    • SAINT-GOBAIN
    • FREUDENBERG MEDICAL
    • THE LUBRIZOL CORPORATION
    • WL GORE & ASSOCIATES, INC.
    • NORDSON CORPORATION
    • TE CONNECTIVITY
    • ELKEM ASA
    • TRELLEBORG AB
    • RAUMEDIC AG
    • TEKNOR APEX
    • SPECTRUM PLASTICS GROUP
    • ZEUS COMPANY LLC
  • 其他公司
    • ATAG SPA
    • DAVIS STANDARD
    • FBK MEDICAL TUBING
    • PROTERIAL CABLE AMERICA, INC.
    • ICO RALLY
    • ICU MEDICAL, INC.
    • KRATON CORPORATION
    • MICROLUMEN INC.
    • MDC INDUSTRIES
    • NEWAGE INDUSTRIES
    • OPTINOVA
    • PARKER HANNIFIN CORP.
    • TEEL PLASTICS
    • VESTA INC.
    • SMOOTH-BOR PLASTICS

第13章 附錄

Product Code: CH 4564

The medical tubing market is projected to reach USD 18.41 billion by 2030 from USD 12.53 billion in 2025, at a CAGR of 8.0% during the forecast period. The expansion in the medical tubing market is due to rise in cases of chronic disease, including cardiovascular conditions, cancer, and respiratory conditions. Many of these illnesses demand medical equipment like catheters, infusion equipment, and ventilators that involve tubing for treatment and management effectiveness. For example, increasing prevalence of respiratory conditions such as asthma and tuberculosis has promoted demand for ventilator tubing systems. The rise in the elderly population, also more prone to chronic diseases and surgery, is another major reason. This increase in the old age population led to an uptrend in need for minimally invasive procedures with medical tubing featuring a key element in drug administration and fluid delivery systems. Moreover, companies' strategic moves, including product launches and mergers, are broadening market coverage and visibility. Finally, rigorous regulatory requirements and government spending on healthcare infrastructure are driving market growth by providing high-quality tubing products for various applications. All these factors together put the medical tubing market in line for long-term growth in the next few years.

Scope of the Report
Years Considered for the Study2022-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD Million), Volume (Kiloton)
SegmentsMaterial, Application, Structure, and Region
Regions coveredNorth America, Europe, Asia Pacific, South America, and Middle East & Africa

"Rubber is the second fastest-growing material in the medical tubing market during the forecast period."

Rubber is the second fastest-growing medical tubing material because of its better flexibility, durability, and biocompatibility, which make it suitable for numerous medical applications. Natural and synthetic rubbers, including silicone, latex, and thermoplastic elastomers (TPE), provide good resistance to harsh temperatures, chemicals, and multiple sterilization cycles. This makes rubber tubing ideally suited to be used in catheters, respiratory therapy units, peristaltic pumps, and surgery drainage systems. Silicone rubber is specifically used on a large scale owing to its superior biocompatibility, for which it is considered a material of choice for implantable and long-term medical uses. In addition, rubber products have higher resilience that allows medical tubing to withstand bending and stretching without loss of integrity, hence offering enhanced patient comfort and device performance. The growing prevalence of chronic conditions, such as cardiovascular and respiratory diseases, has fueled the demand for medical devices that incorporate rubber tubing. In addition, advances in rubber formulations, including antimicrobial coatings and increased tensile strength, have contributed to its applications in critical care. With advances in healthcare innovation, rubber tubing continues to be a top contender, thus qualifying it as the second fastest-growing material in the medical tubing market.

"Braided tubing is the second fastest-growing structure in the medical tubing market during the forecast period."

Braided tubing is the second fastest-growing medical tubing structure because of its excellent combination of strength, flexibility, and versatility that can address a broad spectrum of sophisticated medical uses. Its structure, with a reinforcing braided layer commonly composed of materials such as stainless steel or nylon inserted inside polymer tubing, provides the best resistance to high pressure and kinking than its non-reinforced counterparts. This makes it most appropriate for high-performance applications such as catheters, endoscopes, and cardiovascular devices, where durability and precise fluid delivery are of the highest priority. The growing need for minimally invasive procedures, which require tubing that can navigate through intricate anatomical pathways without compromising performance, significantly enhances its application. Braided tubing can withstand sterilization processes and maintain structural integrity under stress conditions also helps in meeting the strict safety requirements of the medical sector. Rising prevalence of chronic diseases, coupled with the aging population and their requirement for advanced diagnostic and therapeutic equipment, also fuels its market growth. New braiding technology and material science enable it to be even more flexible and enable customization to fulfill particular medical needs. While single-lumen tubing may be the culprit by way of simplicity and ubiquity, the greater mechanical properties and biocompatibility of braided tubing with high-performance uses position it as a fast-rising market that responds well to shifting needs of modern healthcare.

"Catheters & cannulas is the second fastest-growing structure in the medical tubing market during the forecast period."

The catheters & cannulas market is the second fastest-growing application of the medical tubing market owing to a number of major driving factors behind its demand. As the global healthcare systems focus on minimally invasive interventions, catheters & cannulas are becoming the tools of choice, providing safer and less traumatic alternatives to conventional surgeries. These soft tubes play a vital role in uses such as cardiovascular interventions, urinary drainage, and intravenous therapy, where accuracy and patient comfort are of utmost importance. Growing prevalence of chronic illness, including cardiovascular conditions, diabetes, and renal disorders, mainly in aging communities, also catalyzes such expansion. Demand for catheterization in treatment of heart problems or urinary incontinence automatically increases demand for special tubing. Advancements in technology also are contributing factors with improved biocompatible materials, including silicone and polyurethane, improving functionality, longevity, and safety for catheters & cannulas. Besides, the move towards outpatient treatment and home healthcare increases their application in portable equipment, like infusion pumps. The segment is helped by the increasing investments in healthcare, particularly in sectors that are emerging, as enhanced infrastructure and availability of medical services increase the demand for disposable and sterile tubing.

"The Middle East and Africa (MEA) market is projected to register the second fastest growing market for medical tubing during the forecast period."

Middle East & Africa (MEA) is the second fastest-growing market for medical tubing owing to mounting healthcare investment, enhancing medical infrastructure, and rising demand for high-tech medical devices. Regional governments, specifically those of Saudi Arabia, UAE, and South Africa, are greatly investing in the modernization of healthcare, generating the demand for superior medical tubing for usage in hospitals, clinics, and diagnostic centers. The growth of healthcare facilities, coupled with the creation of medical free zones and manufacturing centers, is increasing local production and distribution of medical tubing and associated devices. The increasing incidence of chronic diseases like diabetes, cardiovascular diseases, and respiratory diseases has boosted the use of medical tubing in drug delivery systems, catheters, and respiratory devices. The increased geriatric population in the region also demands advanced medical treatment, thereby propelling the use of medical tubing-based applications. The transition towards home healthcare and wearable medical devices, including insulin pumps and oxygen therapy devices, is another key driver for market growth. Worldwide medical device companies are expanding their reach in the MEA region through collaborations, joint ventures, and establishing regional production units. All this growth increases the number of better-quality medical tubing products available and reduces dependency on imports, and consequently healthcare becomes affordable. Medical tubing technologies such as biodegradable and antimicrobial medical tubing grow more popular in MEA as healthcare professionals continue to prioritize infection control and eco-friendliness.

Extensive primary interviews were conducted to determine and verify the market size for several segments and sub-segments and the information gathered through secondary research.

The break-up of primary interviews is given below:

  • By Department: Tier 1: 40%, Tier 2: 25%, and Tier 3: 35%
  • By Designation: C Level: 35%, Director Level: 30%, and Executives: 35%
  • By Region: North America: 25%, Europe: 45%, Asia Pacific: 20%, South America: 5%, Middle East & Africa 5%

Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), Teknor Apex (US), Spectrum Plastics Group (US) Zeus Company LLC (US) among others are some of the key players in the medical tubing market.

The study includes an in-depth competitive analysis of these key players in the authentication and brand

protection market, with their company profiles, recent developments, and key market strategies.

Research Coverage

The market study covers the medical tubing market across various segments. It aims to estimate the market size and the growth potential of this market across different segments based on material, application, structure, end-use industry, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to improve their position in the medical tubing market.

Key Benefits of Buying the Report

The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall medical tubing market and its segments and sub-segments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the position of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increase in geriatric population, Increasing demand for minimally invasive medical procedures, Stringent quality standards and regulations, Advancements in extrusion technology), restraints (Limited material compatibility), opportunities (Customization and innovation in polymers and tubing structure, Increasing government expenditure for upgrading and developing healthcare infrastructure), challenges (High cost of producing and marketing medical tubing products).
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the medical tubing market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the medical tubing market across varied regions

Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical tubing market

  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Saint-Gobain (France), Freudenberg Medical (US), W. L. Gore & Associates, Inc. (US), The Lubrizol Corporation (US), Nordson Corporation (US), TE Connectivity (Switzerland), Elkem ASA (Norway), Trelleborg AB (Sweden), RAUMEDIC AG (Germany), Teknor Apex (US), Spectrum Plastics Group (US) Zeus Company LLC (US) among others are the top manufacturers covered in the medical tubing market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
    • 1.3.5 UNITS CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 List of key secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 List of primary interview participants-demand and supply side
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of interviews with experts
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 FORECAST NUMBER CALCULATION
  • 2.4 DATA TRIANGULATION
  • 2.5 FACTOR ANALYSIS
  • 2.6 ASSUMPTIONS
  • 2.7 LIMITATIONS AND RISKS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL TUBING MARKET
  • 4.2 MEDICAL TUBING MARKET, BY MATERIAL
  • 4.3 MEDICAL TUBING MARKET, BY APPLICATION
  • 4.4 MEDICAL TUBING MARKET, BY REGION

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growing geriatric population
      • 5.2.1.2 Increasing demand for minimally invasive medical procedures
      • 5.2.1.3 Advancements in extrusion technology
      • 5.2.1.4 Stringent quality standards and regulations
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Limited material compatibility
      • 5.2.2.2 Environmental and disposal concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Advancements in biocompatible and smart materials
      • 5.2.3.2 Increasing government expenditure to upgrade and develop healthcare infrastructure
    • 5.2.4 CHALLENGES
      • 5.2.4.1 High production costs and marketing complexities
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.4.2 BUYING CRITERIA
  • 5.5 MACROECONOMIC INDICATORS
    • 5.5.1 GLOBAL GDP TRENDS

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 VALUE CHAIN ANALYSIS
  • 6.3 REGULATORY LANDSCAPE
    • 6.3.1 REGULATIONS
      • 6.3.1.1 North America
      • 6.3.1.2 Asia Pacific
      • 6.3.1.3 Europe
    • 6.3.2 STANDARDS
      • 6.3.2.1 ISO standard
      • 6.3.2.2 Food and drug administration (FDA)
      • 6.3.2.3 ASTM (American society for testing and materials) standards
    • 6.3.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.4 TRADE ANALYSIS
    • 6.4.1 IMPORT SCENARIO (HS CODE 3917)
    • 6.4.2 EXPORT SCENARIO (HS CODE 3917)
  • 6.5 ECOSYSTEM ANALYSIS
  • 6.6 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 6.7 CASE STUDY ANALYSIS
    • 6.7.1 FREUDENBERG MEDICAL TO PROVIDE SPECIALTY BALLOON CATHETERS
    • 6.7.2 W. L. GORE & ASSOCIATES, INC. PROVIDES GORE STA-PURE PUMP TUBING
  • 6.8 TECHNOLOGY ANALYSIS
    • 6.8.1 KEY TECHNOLOGIES
      • 6.8.1.1 Extrusion technology
      • 6.8.1.2 Advanced material technologies
    • 6.8.2 COMPLEMENTARY TECHNOLOGIES
      • 6.8.2.1 Smart technologies and connectivity
      • 6.8.2.2 Surface treatment and modification
  • 6.9 KEY CONFERENCES AND EVENTS, 2025
  • 6.10 PATENT ANALYSIS
    • 6.10.1 METHODOLOGY
    • 6.10.2 DOCUMENT TYPES
    • 6.10.3 PUBLICATION TRENDS IN LAST 11 YEARS
    • 6.10.4 INSIGHTS
    • 6.10.5 LEGAL STATUS OF PATENTS
    • 6.10.6 JURISDICTION ANALYSIS
    • 6.10.7 TOP APPLICANTS
  • 6.11 IMPACT OF AI/GEN AI ON MEDICAL TUBING MARKET
  • 6.12 PRICING ANALYSIS
    • 6.12.1 AVERAGE SELLING PRICE, BY REGION, 2021-2024
    • 6.12.2 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS, BY KEY PLAYER, 2024
    • 6.12.3 AVERAGE SELLING PRICE TREND, BY MATERIAL, 2021-2024
  • 6.13 INVESTMENT AND FUNDING SCENARIO

7 MEDICAL TUBING MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 BULK DISPOSABLE TUBING
    • 7.2.1 DEMAND FROM HOSPITALS, HOME HEALTHCARE PROVIDERS, AND EMERGENCY CARE PROVIDERS TO BOOST MARKET
    • 7.2.2 DIALYSIS TUBING
      • 7.2.2.1 Growing aging population to drive demand
    • 7.2.3 INTRAVENOUS TUBING
      • 7.2.3.1 Technological advancements to drive market
  • 7.3 CATHETERS & CANNULAS
    • 7.3.1 RISING CARDIOVASCULAR DISEASES AND DEMAND FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO FUEL MARKET GROWTH
    • 7.3.2 CATHETERS
      • 7.3.2.1 Increase in chronic diseases contributing to significant demand
      • 7.3.2.2 Cardiovascular catheters
        • 7.3.2.2.1 Growing elderly population and high incidence of cardiovascular diseases to propel market
      • 7.3.2.3 IV catheters
        • 7.3.2.3.1 Demand for direct delivery of medication and nutrients into bloodstream to fuel growth
      • 7.3.2.4 Urinary catheters
        • 7.3.2.4.1 Rising incidences of urinary tract infections and growing need for advanced technologies to drive demand
    • 7.3.3 CANNULAS
      • 7.3.3.1 Evolving healthcare sector and stringent regulatory requirements to support market growth
  • 7.4 DRUG DELIVERY SYSTEMS
    • 7.4.1 PRECISE DRUG DELIVERY TO TARGET SITES TO DRIVE DEMAND
    • 7.4.2 NASOGASTRIC
      • 7.4.2.1 Need for enteral feeding and drainage to fuel demand
    • 7.4.3 NEBULIZERS
      • 7.4.3.1 Conversion of liquid medications to mists for inhalation to drive market
  • 7.5 OTHER APPLICATIONS
    • 7.5.1 PERISTALTIC PUMP TUBING
      • 7.5.1.1 Wide demand for minimizing contamination to boost market
    • 7.5.2 GAS SUPPLY TUBING
      • 7.5.2.1 Increasing minimally invasive surgeries to support market growth
    • 7.5.3 SMOKE EVACUATION TUBING
      • 7.5.3.1 Popularity of cosmetic procedures and medical tourism to drive market

8 MEDICAL TUBING MARKET, BY MATERIAL

  • 8.1 INTRODUCTION
  • 8.2 PLASTICS
    • 8.2.1 BIOCOMPATIBILITY, CHEMICAL STABILITY, AND COST-EFFECTIVENESS TO BOOST MARKET
    • 8.2.2 POLYVINYL CHLORIDE (PVC)
    • 8.2.3 POLYOLEFIN
      • 8.2.3.1 Polyethylene (PE)
      • 8.2.3.2 Polypropylene (PP)
    • 8.2.4 POLYAMIDE
    • 8.2.5 POLYTETRAFLUOROETHYLENE (PTFE)
    • 8.2.6 POLYETHER ETHER KETONE (PEEK)
    • 8.2.7 POLYCARBONATE (PC)
  • 8.3 RUBBERS
    • 8.3.1 SIGNIFICANT DURABILITY AND RESILIENCE TO DRIVE DEMAND
    • 8.3.2 THERMOPLASTIC ELASTOMER (TPE)
    • 8.3.3 THERMOPLASTIC POLYURETHANE (TPU)
    • 8.3.4 SILICONE
    • 8.3.5 POLYURETHANE (PU)
    • 8.3.6 ETHYLENE PROPYLENE DIENE MONOMER (EPDM)
    • 8.3.7 LATEX
  • 8.4 SPECIALTY POLYMERS
    • 8.4.1 DEMAND FOR SPECIALIZED TREATMENT TO BOOST MARKET
    • 8.4.2 BIOABSORBABLE POLYMERS
    • 8.4.3 ETHYLENE VINYL ACETATE (EVA)
  • 8.5 OTHER MATERIALS

9 MEDICAL TUBING MARKET, BY STRUCTURE

  • 9.1 INTRODUCTION
  • 9.2 SINGLE-LUMEN
    • 9.2.1 DEMAND FOR ADMINISTRATION OF FLUIDS AND MEDICATION, AIRWAY MANAGEMENT, AND PATIENT NUTRITION TO DRIVE MARKET
  • 9.3 CO-EXTRUDED
    • 9.3.1 DURABILITY, LUBRICITY, OPACITY, RADIOPACITY, AND TENSILE STRENGTH TO BOOST MARKET
  • 9.4 MULTI-LUMEN
    • 9.4.1 NON-TOXICITY, BIOCOMPATIBILITY, AND INERTNESS TO FUEL MARKET DEMAND
  • 9.5 TAPERED OR BUMP TUBING
    • 9.5.1 ENHANCED FUNCTIONALITIES IN CVC, PICC, AND DRUG DELIVERY CATHETERS TO DRIVE MARKET
  • 9.6 BRAIDED TUBING
    • 9.6.1 GOOD STRENGTH, STEERABILITY, AND PRESSURE RESISTANCE TO PROPEL MARKET

10 MEDICAL TUBING MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 High disposable income and strong healthcare infrastructure to drive market
    • 10.2.2 CANADA
      • 10.2.2.1 Aging population and increasing healthcare expenditure to support market growth
    • 10.2.3 MEXICO
      • 10.2.3.1 High investments and low manufacturing costs to fuel demand
  • 10.3 EUROPE
    • 10.3.1 GERMANY
      • 10.3.1.1 Advanced medical facilities and R&D investments to propel market
    • 10.3.2 FRANCE
      • 10.3.2.1 Rising elderly population to fuel market growth
    • 10.3.3 UK
      • 10.3.3.1 Innovation, technological advancements, and investments to drive market
    • 10.3.4 SPAIN
      • 10.3.4.1 Growing aging population and improvements in healthcare system to increase consumption
    • 10.3.5 ITALY
      • 10.3.5.1 Growing geriatric population and strong focus on research and innovation to drive market
    • 10.3.6 NETHERLANDS
      • 10.3.6.1 Rising homecare treatment to increase demand
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
      • 10.4.1.1 Investments in manufacturing medical devices to support market
    • 10.4.2 JAPAN
      • 10.4.2.1 Implementation of AI and big data technologies in healthcare industry to increase demand
    • 10.4.3 INDIA
      • 10.4.3.1 Government initiatives, high purchasing power, and rising manufacturing output to fuel demand
    • 10.4.4 SOUTH KOREA
      • 10.4.4.1 Medical tourism to lead to market growth
    • 10.4.5 REST OF ASIA PACIFIC
  • 10.5 MIDDLE EAST & AFRICA
    • 10.5.1 GCC COUNTRIES
      • 10.5.1.1 Saudi Arabia
        • 10.5.1.1.1 Government initiatives to support market growth
      • 10.5.1.2 UAE
        • 10.5.1.2.1 Government funding and rapidly developing private health sector to drive market
    • 10.5.2 SOUTH AFRICA
      • 10.5.2.1 Increasing awareness, testing, and treatment programs to drive market
    • 10.5.3 EGYPT
      • 10.5.3.1 Technological advancements and improving healthcare sector to fuel demand
    • 10.5.4 REST OF MIDDLE EAST & AFRICA
  • 10.6 SOUTH AMERICA
    • 10.6.1 BRAZIL
      • 10.6.1.1 Growing healthcare system to increase consumption
    • 10.6.2 ARGENTINA
      • 10.6.2.1 Rising prevalence of chronic diseases, aging population, and advances in medical sector to drive market
    • 10.6.3 REST OF SOUTH AMERICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020-2025
  • 11.3 REVENUE ANALYSIS, 2024
  • 11.4 MARKET SHARE ANALYSIS, 2024
    • 11.4.1 SAINT-GOBAIN
    • 11.4.2 FREUDENBERG MEDICAL
    • 11.4.3 THE LUBRIZOL CORPORATION
    • 11.4.4 W. L. GORE & ASSOCIATES, INC.
    • 11.4.5 TE CONNECTIVITY
  • 11.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 11.6 BRAND COMPARISON
    • 11.6.1 MEDICAL TUBING MARKET: BRAND COMPARISON
    • 11.6.2 BIO-SIL TUBING
    • 11.6.3 HELIXFLEX
    • 11.6.4 ISOPLAST ETPU MEDICAL TUBING
    • 11.6.5 GORE STA-PURE PUMP TUBING SERIES PFL
  • 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 11.7.1 STARS
    • 11.7.2 EMERGING LEADERS
    • 11.7.3 PERVASIVE PLAYERS
    • 11.7.4 PARTICIPANTS
    • 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 11.7.5.1 Company footprint
      • 11.7.5.2 Region footprint
      • 11.7.5.3 Structure footprint
      • 11.7.5.4 Material footprint
      • 11.7.5.5 Application footprint
  • 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.8.1 PROGRESSIVE COMPANIES
    • 11.8.2 RESPONSIVE COMPANIES
    • 11.8.3 DYNAMIC COMPANIES
    • 11.8.4 STARTING BLOCKS
    • 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 11.8.5.1 Detailed list of key startups/SMEs
      • 11.8.5.2 Competitive benchmarking of startups/SMEs
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES
    • 11.9.2 DEALS
    • 11.9.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 SAINT-GOBAIN
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products/Solutions/Services offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Deals
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Right to win
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses and competitive threats
    • 12.1.2 FREUDENBERG MEDICAL
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products/Solutions/Services offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Product launches
        • 12.1.2.3.2 Deals
        • 12.1.2.3.3 Expansions
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Right to win
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses and competitive threats
    • 12.1.3 THE LUBRIZOL CORPORATION
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products/Solutions/Services offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Deals
        • 12.1.3.3.2 Expansions
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Right to win
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses and competitive threats
    • 12.1.4 W. L. GORE & ASSOCIATES, INC.
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products/Solutions/Services offered
      • 12.1.4.3 MnM view
        • 12.1.4.3.1 Right to win
        • 12.1.4.3.2 Strategic choices
        • 12.1.4.3.3 Weaknesses and competitive threats
    • 12.1.5 NORDSON CORPORATION
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products/Solutions/Services offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Deals
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Right to win
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses and competitive threats
    • 12.1.6 TE CONNECTIVITY
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products/Solutions/Services offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Product launches
      • 12.1.6.4 MnM view
    • 12.1.7 ELKEM ASA
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products/Solutions/Services offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Deals
        • 12.1.7.3.2 Expansions
      • 12.1.7.4 MnM view
    • 12.1.8 TRELLEBORG AB
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products/Solutions/Services offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Deals
        • 12.1.8.3.2 Other developments
      • 12.1.8.4 MnM view
    • 12.1.9 RAUMEDIC AG
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products/Solutions/Services offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Product launches
        • 12.1.9.3.2 Deals
        • 12.1.9.3.3 Expansions
      • 12.1.9.4 MnM view
    • 12.1.10 TEKNOR APEX
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products/Solutions/Services offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Product launches
        • 12.1.10.3.2 Deals
      • 12.1.10.4 MnM view
    • 12.1.11 SPECTRUM PLASTICS GROUP
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products/Solutions/Services offered
      • 12.1.11.3 Recent developments
        • 12.1.11.3.1 Deals
        • 12.1.11.3.2 Expansions
      • 12.1.11.4 MnM view
    • 12.1.12 ZEUS COMPANY LLC
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products/Solutions/Services offered
      • 12.1.12.3 Recent developments
        • 12.1.12.3.1 Product launches
        • 12.1.12.3.2 Expansions
      • 12.1.12.4 MnM view
  • 12.2 OTHER PLAYERS
    • 12.2.1 ATAG SPA
    • 12.2.2 DAVIS STANDARD
    • 12.2.3 FBK MEDICAL TUBING
    • 12.2.4 PROTERIAL CABLE AMERICA, INC.
    • 12.2.5 ICO RALLY
    • 12.2.6 ICU MEDICAL, INC.
    • 12.2.7 KRATON CORPORATION
    • 12.2.8 MICROLUMEN INC.
    • 12.2.9 MDC INDUSTRIES
    • 12.2.10 NEWAGE INDUSTRIES
    • 12.2.11 OPTINOVA
    • 12.2.12 PARKER HANNIFIN CORP.
    • 12.2.13 TEEL PLASTICS
    • 12.2.14 VESTA INC.
    • 12.2.15 SMOOTH-BOR PLASTICS

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 LIST OF KEY SECONDARY SOURCES
  • TABLE 2 SHARE OF POPULATION ABOVE 65 YEARS OF AGE, BY COUNTRY, 2020
  • TABLE 3 LIST OF STANDARDS AND REGULATIONS FOR MEDICAL TUBING
  • TABLE 4 CAPITAL HEALTHCARE EXPENDITURE, 2020-2023 (USD MILLION)
  • TABLE 5 HEALTHCARE SPENDING, 2023 (USD MILLION)
  • TABLE 6 MEDICAL TUBING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS (%)
  • TABLE 8 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • TABLE 9 TRENDS OF PER CAPITA GDP, BY KEY COUNTRY, 2020-2023 (USD)
  • TABLE 10 GDP GROWTH ESTIMATE AND PROJECTION, BY KEY COUNTRY, 2024-2027 (USD)
  • TABLE 11 HEALTH EXPENDITURE AS PERCENTAGE OF GDP, BY KEY COUNTRY, 2019-2022
  • TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 IMPORT SCENARIO FOR HS CODE 3917-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 16 EXPORT SCENARIO FOR HS CODE 3917-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 17 ROLE OF COMPANIES IN MEDICAL TUBING ECOSYSTEM
  • TABLE 18 MEDICAL TUBING MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025
  • TABLE 19 TOP 10 PATENT OWNERS DURING LAST ELEVEN YEARS, 2015-2024
  • TABLE 20 MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 21 MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 22 MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 23 MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 24 MEDICAL TUBING MARKET, BY MATERIAL, 2021-2024 (KILOTON)
  • TABLE 25 MEDICAL TUBING MARKET, BY MATERIAL, 2025-2030 (KILOTON)
  • TABLE 26 MEDICAL TUBING MARKET, BY MATERIAL, 2021-2024 (USD MILLION)
  • TABLE 27 MEDICAL TUBING MARKET, BY MATERIAL, 2025-2030 (USD MILLION)
  • TABLE 28 MEDICAL TUBING MARKET, BY STRUCTURE, 2021-2024 (KILOTON)
  • TABLE 29 MEDICAL TUBING MARKET, BY STRUCTURE, 2025-2030 (KILOTON)
  • TABLE 30 MEDICAL TUBING MARKET, BY STRUCTURE, 2021-2024 (USD MILLION)
  • TABLE 31 MEDICAL TUBING MARKET, BY STRUCTURE, 2025-2030 (USD MILLION)
  • TABLE 32 MEDICAL TUBING MARKET, BY REGION, 2021-2024 (KILOTON)
  • TABLE 33 MEDICAL TUBING MARKET, BY REGION, 2025-2030 (KILOTON)
  • TABLE 34 MEDICAL TUBING MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 35 MEDICAL TUBING MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 36 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2021-2024 (KILOTON)
  • TABLE 37 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2025-2030 (KILOTON)
  • TABLE 38 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 39 NORTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 40 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 41 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 42 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 43 NORTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 44 US: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 45 US: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 46 US: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 47 US: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 48 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 49 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 50 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 51 CANADA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 52 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 53 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 54 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 55 MEXICO: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 56 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2021-2024 (KILOTON)
  • TABLE 57 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2025-2030 (KILOTON)
  • TABLE 58 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 59 EUROPE: MEDICAL TUBING MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 60 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 61 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 62 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 63 EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 64 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 65 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 66 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 67 GERMANY: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 68 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 69 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 70 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 71 FRANCE: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 72 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 73 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 74 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 75 UK: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 76 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 77 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 78 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 79 SPAIN: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 80 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 81 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 82 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 83 ITALY: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 84 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 85 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 86 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 87 NETHERLANDS: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 88 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 89 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 90 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 91 REST OF EUROPE: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 92 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY, 2021-2024 (KILOTON)
  • TABLE 93 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY, 2025-2030 (KILOTON)
  • TABLE 94 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: MEDICAL TUBING MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 97 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 98 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 100 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 101 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 102 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 103 CHINA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 104 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 105 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 106 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 107 JAPAN: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 108 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 109 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 110 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 111 INDIA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 112 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 113 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 114 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 115 SOUTH KOREA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 116 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 117 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 118 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 119 REST OF ASIA PACIFIC: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 120 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY, 2021-2024 (KILOTON)
  • TABLE 121 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY, 2025-2030 (KILOTON)
  • TABLE 122 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 123 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 124 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 125 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 126 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 127 MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 128 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 129 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 130 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 131 SAUDI ARABIA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 132 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 133 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 134 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 135 UAE: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 136 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 137 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 138 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 139 SOUTH AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 140 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 141 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 142 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 143 EGYPT: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 144 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 145 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 146 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 147 REST OF MIDDLE EAST & AFRICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 148 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2021-2024 (KILOTON)
  • TABLE 149 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2025-2030 (KILOTON)
  • TABLE 150 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 151 SOUTH AMERICA: MEDICAL TUBING MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 152 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 153 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 154 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 155 SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 156 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 157 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 158 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 159 BRAZIL: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 160 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 161 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 162 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 163 ARGENTINA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 164 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (KILOTON)
  • TABLE 165 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (KILOTON)
  • TABLE 166 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2021-2024 (USD MILLION)
  • TABLE 167 REST OF SOUTH AMERICA: MEDICAL TUBING MARKET, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 168 MEDICAL TUBING MARKET: OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS, 2020-2025
  • TABLE 169 MEDICAL TUBING MARKET: DEGREE OF COMPETITION, 2024
  • TABLE 170 MEDICAL TUBING MARKET: REGION FOOTPRINT
  • TABLE 171 MEDICAL TUBING MARKET: STRUCTURE FOOTPRINT
  • TABLE 172 MEDICAL TUBING MARKET: MATERIAL FOOTPRINT
  • TABLE 173 MEDICAL TUBING MARKET: APPLICATION FOOTPRINT
  • TABLE 174 MEDICAL TUBING MARKET: KEY STARTUPS/SMES
  • TABLE 175 MEDICAL TUBING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 176 MEDICAL TUBING MARKET: PRODUCT LAUNCHES, JANUARY 2020-MARCH 2025
  • TABLE 177 MEDICAL TUBING MARKET: DEALS, JANUARY 2020-MARCH 2025
  • TABLE 178 MEDICAL TUBING MARKET: OTHER DEVELOPMENTS, JANUARY 2020-MARCH 2025
  • TABLE 179 SAINT-GOBAIN: COMPANY OVERVIEW
  • TABLE 180 SAINT-GOBAIN: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 181 SAINT-GOBAIN: DEALS, JANUARY 2020-MARCH 2025
  • TABLE 182 FREUDENBERG MEDICAL: COMPANY OVERVIEW
  • TABLE 183 FREUDENBERG MEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 184 FREUDENBERG MEDICAL: PRODUCT LAUNCHES, JANUARY 2020-MARCH 2025
  • TABLE 185 FREUDENBERG MEDICAL: DEALS, JANUARY 2020-MARCH 2025
  • TABLE 186 FREUDENBERG MEDICAL: EXPANSIONS, JANUARY 2020-MARCH 2025
  • TABLE 187 THE LUBRIZOL CORPORATION: COMPANY OVERVIEW
  • TABLE 188 THE LUBRIZOL CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 189 THE LUBRIZOL CORPORATION: DEALS, JANUARY 2020-MARCH 2025
  • TABLE 190 THE LUBRIZOL CORPORATION: EXPANSIONS, JANUARY 2020-MARCH 2025
  • TABLE 191 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW
  • TABLE 192 W. L. GORE & ASSOCIATES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 193 NORDSON CORPORATION: COMPANY OVERVIEW
  • TABLE 194 NORDSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 195 NORDSON CORPORATION: DEALS, JANUARY 2020-MARCH 2025
  • TABLE 196 TE CONNECTIVITY: COMPANY OVERVIEW
  • TABLE 197 TE CONNECTIVITY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 198 TE CONNECTIVITY: PRODUCT LAUNCHES, JANUARY 2020-MARCH 2025
  • TABLE 199 ELKEM ASA: COMPANY OVERVIEW
  • TABLE 200 ELKEM ASA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 201 ELKEM ASA: DEALS, JANUARY 2020-MARCH 2025
  • TABLE 202 ELKEM ASA: EXPANSIONS, JANUARY 2020-MARCH 2025
  • TABLE 203 TRELLEBORG AB: COMPANY OVERVIEW
  • TABLE 204 TRELLEBORG AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 205 TRELLEBORG AB: DEALS, JANUARY 2020-MARCH 2025
  • TABLE 206 TRELLEBORG AB: OTHER DEVELOPMENTS, JANUARY 2020-MARCH 2025
  • TABLE 207 RAUMEDIC AG: COMPANY OVERVIEW
  • TABLE 208 RAUMEDIC AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 209 RAUMEDIC AG: PRODUCT LAUNCHES, JANUARY 2020-MARCH 2025
  • TABLE 210 RAUMEDIC AG: DEALS, JANUARY 2020-MARCH 2025
  • TABLE 211 RAUMEDIC AG: EXPANSIONS, JANUARY 2020-MARCH 2025
  • TABLE 212 TEKNOR APEX: COMPANY OVERVIEW
  • TABLE 213 TEKNOR APEX: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 214 TEKNOR APEX: PRODUCT LAUNCHES, JANUARY 2020-MARCH 2025
  • TABLE 215 TEKNOR APEX: DEALS, JANUARY 2020-MARCH 2025
  • TABLE 216 SPECTRUM PLASTICS GROUP: COMPANY OVERVIEW
  • TABLE 217 SPECTRUM PLASTICS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 218 SPECTRUM PLASTICS GROUP: DEALS, JANUARY 2020-MARCH 2025
  • TABLE 219 SPECTRUM PLASTICS GROUP: EXPANSIONS, JANUARY 2020-MARCH 2025
  • TABLE 220 ZEUS COMPANY LLC: COMPANY OVERVIEW
  • TABLE 221 ZEUS COMPANY LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 222 ZEUS COMPANY LLC: PRODUCT LAUNCHES, JANUARY 2020-MARCH 2025
  • TABLE 223 ZEUS COMPANY LLC: EXPANSIONS, JANUARY 2020-MARCH 2025
  • TABLE 224 ATAG SPA: COMPANY OVERVIEW
  • TABLE 225 DAVIS STANDARD: COMPANY OVERVIEW
  • TABLE 226 FBK MEDICAL TUBING: COMPANY OVERVIEW
  • TABLE 227 PROTERIAL CABLE AMERICA, INC.: COMPANY OVERVIEW
  • TABLE 228 ICO RALLY: COMPANY OVERVIEW
  • TABLE 229 ICU MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 230 KRATON CORPORATION: COMPANY OVERVIEW
  • TABLE 231 MICROLUMEN INC.: COMPANY OVERVIEW
  • TABLE 232 MDC INDUSTRIES: COMPANY OVERVIEW
  • TABLE 233 NEWAGE INDUSTRIES: COMPANY OVERVIEW
  • TABLE 234 OPTINOVA: COMPANY OVERVIEW
  • TABLE 235 PARKER HANNIFIN CORP.: COMPANY OVERVIEW
  • TABLE 236 TEEL PLASTICS: COMPANY OVERVIEW
  • TABLE 237 VESTA INC.: COMPANY OVERVIEW
  • TABLE 238 SMOOTH-BOR PLASTICS: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 MEDICAL TUBING MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 MEDICAL TUBING MARKET: RESEARCH DESIGN
  • FIGURE 3 MEDICAL TUBING MARKET: BOTTOM-UP APPROACH
  • FIGURE 4 MEDICAL TUBING MARKET: TOP-DOWN APPROACH
  • FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL TUBING MARKET, TOP-DOWN APPROACH
  • FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS
  • FIGURE 7 MEDICAL TUBING MARKET: DATA TRIANGULATION
  • FIGURE 8 RUBBERS TO BE FASTEST-GROWING MATERIAL SEGMENT IN MEDICAL TUBING MARKET DURING FORECAST PERIOD
  • FIGURE 9 CATHETERS & CANNULAS APPLICATION TO LEAD OVERALL MARKET DURING FORECAST PERIOD
  • FIGURE 10 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD
  • FIGURE 11 ASIA PACIFIC TO REGISTER HIGHEST GROWTH IN MEDICAL TUBING MARKET DURING FORECAST PERIOD
  • FIGURE 12 SPECIALTY POLYMERS SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 13 BULK DISPOSABLE TUBING SEGMENT TO LEAD OVERALL MARKET BY 2030
  • FIGURE 14 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL TUBING MARKET
  • FIGURE 16 MEDICAL TUBING MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS
  • FIGURE 18 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS
  • FIGURE 19 MEDICAL TUBING MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 20 IMPORT DATA FOR HS CODE 3917-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2020-2024 (USD MILLION)
  • FIGURE 21 EXPORT DATA RELATED TO HS CODE 3917-COMPLIANT PRODUCTS, BY KEY COUNTRY, 2020-2024 (USD MILLION)
  • FIGURE 22 MEDICAL TUBING MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 23 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS IN MEDICAL TUBING MARKET
  • FIGURE 24 MEDICAL TUBING MARKET: GRANTED PATENTS, 2015-2024
  • FIGURE 25 NUMBER OF PATENTS PER YEAR, 2015-2024
  • FIGURE 26 LEGAL STATUS OF PATENTS, 2015-2024
  • FIGURE 27 TOP JURISDICTION, BY DOCUMENT, 2015-2024
  • FIGURE 28 TOP 10 PATENT APPLICANTS, 2015-2024
  • FIGURE 29 AVERAGE SELLING PRICE, BY REGION, 2021-2024 (USD/KG)
  • FIGURE 30 AVERAGE SELLING PRICE FOR TOP THREE APPLICATIONS, BY KEY PLAYER, 2024 (USD/KG)
  • FIGURE 31 AVERAGE SELLING PRICE TREND, BY MATERIAL, 2021-2024 (USD/KG)
  • FIGURE 32 MEDICAL TUBING, INVESTMENT AND FUNDING SCENARIO, 2020-2024
  • FIGURE 33 CATHETERS & CANNULAS TO BE LARGEST APPLICATION OF MEDICAL TUBING MARKET DURING FORECAST PERIOD
  • FIGURE 34 RUBBERS SEGMENT TO DOMINATE MEDICAL TUBING MARKET DURING FORECAST PERIOD
  • FIGURE 35 MULTI-LUMEN SEGMENT TO DOMINATE MEDICAL TUBING MARKET DURING FORECAST PERIOD
  • FIGURE 36 INDIA TO BE FASTEST-GROWING MARKET FOR MEDICAL TUBING DURING FORECAST PERIOD
  • FIGURE 37 NORTH AMERICA: MEDICAL TUBING MARKET SNAPSHOT
  • FIGURE 38 EUROPE: MEDICAL TUBING MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: MEDICAL TUBING MARKET SNAPSHOT
  • FIGURE 40 MEDICAL TUBING MARKET: REVENUE ANALYSIS OF KEY COMPANIES, 2021-2023
  • FIGURE 41 MEDICAL TUBING MARKET SHARE ANALYSIS, 2024
  • FIGURE 42 MEDICAL TUBING MARKET: COMPANY VALUATION OF LEADING COMPANIES, 2024
  • FIGURE 43 MEDICAL TUBING MARKET: FINANCIAL METRICS OF LEADING COMPANIES, 2024
  • FIGURE 44 BRAND COMPARISON
  • FIGURE 45 COMPANY EVALUATION MATRIX, KEY PLAYERS, 2024
  • FIGURE 46 MEDICAL TUBING MARKET: COMPANY FOOTPRINT
  • FIGURE 47 MEDICAL TUBING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 48 SAINT-GOBAIN: COMPANY SNAPSHOT
  • FIGURE 49 FREUDENBERG GROUP: COMPANY SNAPSHOT
  • FIGURE 50 NORDSON CORPORATION: COMPANY SNAPSHOT
  • FIGURE 51 TE CONNECTIVITY: COMPANY SNAPSHOT
  • FIGURE 52 ELKEM ASA: COMPANY SNAPSHOT
  • FIGURE 53 TRELLEBORG AB: COMPANY SNAPSHOT